Abstract Details
|
Adrienne Boire, MD, PhD, FAAN
(Memorial Sloan-Kettering)
PRESENTER |
Dr. Boire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apelis Pharmaceuticals. The institution of Dr. Boire has received research support from National Cancer Institute. The institution of Dr. Boire has received research support from Center for Experimental Therapeutics. The institution of Dr. Boire has received research support from STARR Cancer Consortium. The institution of Dr. Boire has received research support from National Cancer Institute. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Mariza Daras, MD (VCU) | Dr. Daras has nothing to disclose. |
| Thomas J. Kaley, MD (Memorial Sloan-Kettering Cancer Center) | Dr. Kaley has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Lisa M. DeAngelis, MD, FAAN (Memorial Sloan-Kettering Cancer Center) | Dr. DeAngelis has received publishing royalties from a publication relating to health care. |
| No disclosure on file |